Symbol | Börsvärde | Pris | Förändring % | Volym | Rel Volume | P/E-tal | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sektor | Analytisk bedömning |
---|---|---|---|---|---|---|---|---|---|---|---|
CSJCSL LTD | 80.059 B CHF | 164.027 CHF | −2.94% | 24 | 0.20 | 36.45 | 4.50 CHF | −0.85% | 1.37% | Health Technology | Köp |
0QFMODERNA INC | 38.169 B CHF | 99.278 CHF | +5.61% | 6 | 0.08 | — | −10.44 CHF | −156.54% | 0.00% | Health Technology | Köp |
22UABIONTECH SE DR | 19.179 B CHF | 81.401 CHF | +1.11% | 2 | 0.03 | 23.58 | 3.45 CHF | −90.50% | 0.00% | Health Technology | Köp |
BM8BIOMARIN PHARMA | 15.851 B CHF | 80.909 CHF | +2.86% | 100 | 0.86 | 110.31 | 0.73 CHF | +8.63% | 0.00% | Health Technology | Köp |
1CGCRISPR THERAPEUTIC | 4.326 B CHF | 52.283 CHF | −0.30% | 30 | 0.23 | — | −1.66 CHF | +78.56% | 0.00% | Health Technology | Köp |
MORMORPHOSYS | 2.496 B CHF | 66.110 CHF | +0.60% | 100 | 0.78 | — | −5.34 CHF | −21.86% | 0.00% | Health Technology | Neutral |
PPGNPOLYPEPTIDE N | 971.119 M CHF | 29.15 CHF | −0.85% | 766 | 0.03 | — | −1.52 CHF | −198.61% | 0.00% | Health Technology | Neutral |
LWBMESOBLAST LTD | 621.209 M CHF | 0.501 CHF | — | 2 K | — | — | — | — | 0.00% | Health Technology | Stark köp |
8EMEDITAS MEDICINE IN | 402.934 M CHF | 4.895 CHF | −47.52% | 3 K | 28.96 | — | −1.73 CHF | +41.62% | 0.00% | Health Technology | Köp |
AXD2HERON THERAPEUTICS | 364.848 M CHF | 2.724 CHF | — | 2.74 K | — | — | −0.73 CHF | +53.89% | 0.00% | Health Technology | Stark köp |
KURNKUROS N | 235.291 M CHF | 7.09 CHF | +5.35% | 115.236 K | 0.41 | — | −0.38 CHF | −63.13% | 0.00% | Health Technology | Stark köp |
6MLMOLECULAR PARTNERS | 118.563 M CHF | 3.403 CHF | −6.64% | 500 | 0.82 | — | −1.89 CHF | −152.70% | 0.00% | Health Technology | Neutral |
MOLNMOLECULAR PARTNERS N | 118.563 M CHF | 3.260 CHF | −4.54% | 3.428 K | 0.38 | — | −1.89 CHF | −152.70% | 0.00% | Health Technology | Neutral |